Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma
文献类型：期刊论文
| 作者 | Xu, Li1; Wang, Yingcong2; Wang, Guanli1; Guo, Shushan1; Yu, Dandan2; Feng, Qilin1; Hu, Ke1; Chen, Gege1,2; Li, Bo3,4,5; Xu, Zhijian3,4,5
|
| 刊名 | LEUKEMIA
 |
| 出版日期 | 2023-05-08 |
| 页码 | 4 |
| ISSN号 | 0887-6924 |
| DOI | 10.1038/s41375-023-01925-w |
| 通讯作者 | Shi, Jumei(shijumei@tongji.edu.cn) |
| 资助项目 | National Natural Science Foundation of China[82170200] ; National Natural Science Foundation of China[81870158] ; National Natural Science Foundation of China[82070224] ; National Natural Science Foundation of China[81900207] ; National Natural Science Foundation of China[82000220] ; National Natural Science Foundation of China[81971529] ; National Natural Science Foundation of China[22077131] ; Chinese Pharmaceutical Association-Yiling Biopharmaceutical Innovation Project[CPAYLJ201908] |
| WOS研究方向 | Oncology ; Hematology |
| 语种 | 英语 |
| WOS记录号 | WOS:000984616200003 |
| 出版者 | SPRINGERNATURE |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/306514]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Shi, Jumei |
| 作者单位 | 1.Tongji Univ, Shanghai East Hosp, Dept Hematol, Sch Med, Shanghai 200120, Peoples R China 2.Tongji Univ, Shanghai Peoples Hosp 10, Dept Hematol, Sch Med, Shanghai 200072, Peoples R China 3.Chinese Acad Sci, Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 5.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China 6.Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Myeloma Ctr, Dept Internal Med, Little Rock, AR 72205 USA |
| 推荐引用方式 GB/T 7714 | Xu, Li,Wang, Yingcong,Wang, Guanli,et al. Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma[J]. LEUKEMIA,2023:4. |
| APA | Xu, Li.,Wang, Yingcong.,Wang, Guanli.,Guo, Shushan.,Yu, Dandan.,...&Shi, Jumei.(2023).Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.LEUKEMIA,4. |
| MLA | Xu, Li,et al."Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma".LEUKEMIA (2023):4. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。